Clinical TrialID 7410

Hesperidin and Diosmin Effect on Metabolic Syndrome

NCT05243238

Metabolic Syndrome and Diabetic Neuropathy

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
7410
Evidence Id
7410
Core Evidence Id
7410
Source Clinical Trial Id
7405
Herb2 Clinical Trial Id
HBCT007405
Nct Id
NCT05243238
Title
Hesperidin and Diosmin Effect on Metabolic Syndrome
Status
Completed
Phase
Study Result
No
Study Condition
Metabolic Syndrome and Diabetic Neuropathy
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Intervention
DIETARY_SUPPLEMENT: dietary supplement flavonoids
Intervention Allocation
Randomized
Intervention Model
Parallel
Intervention Mask
Intervention Purpose
Treatment
Gender
All
Age
Adult, Older_Adult
Enrollment
129
Outcome Measure
metabolic syndrome components, Waist circumference, (cm), 12 weeks|metabolic syndrome components, FBG, mg/dl, 12 weeks|metabolic syndrome components, LDL, mg/dl, 12 weeks|metabolic syndrome components, HDL, 12 weeks|metabolic syndrome components, TGs, mg/dl, 12 weeks|MNSI score for neuropathy, neuropathy improvement if MNSI score decreased, 12 weeks
Sponsor Collaborator
Beni-Suef University
Funded By
OTHER
Location
University, Fayoum, 13556, Egypt
Other Id
FMBSU REC FWA#: FWA00015574
Start Date
2020-03-01
Primary Completion Date
2020-11-30
Completion Date
2021-11-12
First Posted
2022-02-17
Results First Posted
Last Update Posted
2022-02-17
Study Document
Study Url
https://clinicaltrials.gov/study/NCT05243238
Title Cn
Title En
Hesperidin and Diosmin Effect on Metabolic Syndrome
Bilingual Status
semi_complete